Pfizer CEO: COVID Preventive Could Be Ready In 2022

Axios reports:

An oral antiviral drug to stop the virus that causes COVID-19 from replicating could be ready next year “if all goes right,” Pfizer CEO Albert Bourla told CNBC on Tuesday, adding that the drug should work against all variants of the virus.

Why it matters: Antiviral drugs can be a key pandemic-fighting tool, since not everyone will get a vaccine and it may take years to fully vaccinate people in certain countries around the world, Axios’ Alison Snyder reports.

Read the full article.

NEW: Pfizer CEO Albert Bourla said an oral antiviral drug to prevent COVID-19 could be ready next year https://t.co/M1ja7rqVnr

— Axios (@axios) April 27, 2021